Get started
Granules India LimitedGranules India LimitedGranules India Limited

Granules India Limited

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with Granules India Limited



Key stats


Market capitalization
‪218.09 B‬ INR
Dividend yield (indicated)
0.20%
Price to earnings Ratio (TTM)
36.95
Basic EPS (TTM)
24.45 INR
Net income (FY)
‪5.95 B‬ INR
Revenue (FY)
‪53.66 B‬ INR
Shares float
‪150.36 M‬
Beta (1Y)
0.57

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪6.52 K‬
Change (1Y)
+357+5.79%
Revenue / Employee (1Y)
‪8.23 M‬ INR
Net income / Employee (1Y)
‪912.19 K‬ INR

Profile


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Krishna Prasad Chigurupati
Website
granulesindia.com
Headquarters
Hyderabad
Founded
1991
IPO date
Sep 20, 1995
ISIN
INE101D01020
FIGI
BBG000LH28D4
Identifiers
ISIN INE101D01020
CFI code
ESVUFN
Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. It operates through the following business segments: Active Pharmaceutical Ingredient, Pharmaceutical Formulation Intermediates, and Finished Dosages. The company was founded by Krishna Prasad Chigurupati on March 18, 1991 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of GRANULES is 879.30 INR — it has increased by 0.48% in the past 24 hours. Watch Granules India Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Granules India Limited stocks are traded under the ticker GRANULES.
GRANULES stock has fallen by −1.21% compared to the previous week, the month change is a 13.22% rise, over the last year Granules India Limited has showed a 75.09% increase.
We've gathered analysts' opinions on Granules India Limited future price: according to them, GRANULES price has a max estimate of 963.00 INR and a min estimate of 730.00 INR. Watch GRANULES chart and read a more detailed Granules India Limited stock forecast: see what analysts think of Granules India Limited and suggest that you do with its stocks.
GRANULES reached its all-time high on Jul 16, 2026 with the price of 910.00 INR, and its all-time low was 2.80 INR and was reached on Oct 27, 2008. View more price dynamics on GRANULES chart.
See other stocks reaching their highest and lowest prices.
GRANULES stock is 3.24% volatile and has beta coefficient of 0.57. Track Granules India Limited stock price on the chart and check out the list of the most volatile stocks — is Granules India Limited there?
Today Granules India Limited has the market capitalization of ‪223.80 B‬, it has decreased by −1.94% over the last week.
Yes, you can track Granules India Limited financials in yearly and quarterly reports right on TradingView.
Granules India Limited is going to release the next earnings report on Jul 21, 2026. Keep track of upcoming events with our Earnings Calendar.
GRANULES earnings for the last quarter are 7.55 INR per share, whereas the estimation was 6.05 INR resulting in a 24.79% surprise. The estimated earnings for the next quarter are 7.70 INR per share. See more details about Granules India Limited earnings.
Granules India Limited revenue for the last quarter amounts to ‪14.71 B‬ INR, despite the estimated figure of ‪14.30 B‬ INR. In the next quarter, revenue is expected to reach ‪15.01 B‬ INR.
GRANULES net income for the last quarter is ‪2.02 B‬ INR, while the quarter before that showed ‪1.50 B‬ INR of net income which accounts for 0.00% change. Track more Granules India Limited financial stats to get the full picture.
Granules India Limited dividend yield was 0.28% in 2025, and payout ratio reached 7.15%. The year before the numbers were 0.31% and 7.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 21, 2026, the company has ‪6.52 K‬ employees. See our rating of the largest employees — is Granules India Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Granules India Limited EBITDA is ‪11.85 B‬ INR, and current EBITDA margin is 22.49%. See more stats in Granules India Limited financial statements.
Like other stocks, GRANULES shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Granules India Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Granules India Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Granules India Limited stock shows the strong buy signal. See more of Granules India Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.